ARAGEN LIFE SCIENCES LIMITED (91159634)
IPO (In Principle): ARAGEN LIFE SCIENCES LIMITED
📋 IPO IN-PRINCIPLE APPROVAL — ARAGEN LIFE SCIENCES LIMITED
_Aragen Life Sciences Limited provides contract research and development services to pharmaceutical and biotechnology companies_
Issue Size: ₹32.00bn
Est. Mcap: ₹10,667–21,333cr
Face Value: ₹10
Industry: Pharmaceuticals & Biotechnology
Exchange: BSE And NSE
Promoters: Davinder Singh Brar, Aparna Reddy Gunapati, Keshav Gunupati Venkat Reddy
BRLM: Axis Capital Limited, Citigroup Global Markets India Private Limited, Goldman Sachs (India) Securities Private Limited, Other LM / BRLM
Eligibility: Regulation 6(1)
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 91159634 — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add 91159634 to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on ARAGEN LIFE SCIENCES LIMITED
Important.
The summary above is generated automatically from ARAGEN LIFE SCIENCES LIMITED's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.